Skip to main content
OpenTrials

Clinical trial condition

CANCER,NOS

Explore clinical trials studying CANCER,NOS. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

CANCER,NOS trial results

Completed

A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors

NCT01714739

Conditions
CANCER,NOS, Neoplasms
Locations
  • Ucsf San Francisco, California, United States
  • Florida Cancer Affiliates - Ocala Ocala, Florida, United States
  • University Of Chicago Medical Center Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Lutherville, Maryland, United States
View all 30 locations
View Trial Details

Related conditions